Genetic relatedness of Burkholderia (Pseudomonas) cepacia isolates from five cystic fibrosis centers in Michigan

Respiratory Medicine

Volumn 91, Issue 8, 1997, Pages 485-492

  Kumar, A ^a   Dietrich, S ^b   Schneider, W ^b   Jacobson, R ^b   Pouch Downes, F ^b   Robinson Dunn, B E ^b   Honicky, R ^a   Smith, J ^b   Martin, R ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID ESTER;

ARTICLE; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA DETERMINATION; GENETIC ANALYSIS; LIPID COMPOSITION; NONHUMAN; PRIORITY JOURNAL; RESTRICTION MAPPING; UNITED STATES;

EID: 0030800990     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90114-1     Document Type: Article

References (25)

1. Thomassen MJ, Demko CA, Klinger JD, Stern RC. Pseudomonas cepacia colonization among patients with cystic fibrosis. Am Rev Respir Dis 1985; 131: 791-796.
2. LiPuma JJ, Dasen SE, Nielsen DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990; 336: 1094-1096.
3. Taylor RFH, Dalla Costa L, Kaufmann ME, Pitt TL, Hodson ME. Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring? J Hosp Infect 1992; 21: 199-204.
4. Millar-Jones L, Paull A, Saunders Z, Goodchild MC. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet 1992; 340: 491.
5. Larsen GY, Stull TL, Burns JL. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol 1993; 31: 788-792.
6. Govan JRW, Brown PH, Maddison J et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342: 15-19.
7. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: Evidence of person-to-person transmission. J Clin Microbiol 1993; 31: 3017-3022.
8. Rabkin CS, Jarvis WR, Anderson RL, Gown J, Klinger J, LiPuma J, Martone WJ, Monteil H, Richard C, Shigeta S, Sosa A, Stull T, Swenson J, Woods D. Pseudomonas cepacia typing systems: Collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis 1989; 11: 600-607.
9. Mukwaya GM, Welch DF. Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol 1989; 27: 2640-2646.
10. Moss CW, Dees SB. Cellular fatty acids and metabolic products of Pseudomonas species obtained from clinical specimens. J Clin Microbiol 1976; 4: 492-502.
11. LiPuma JJ, Mortensen JE, Dasen SE, Edlind TD, Schidlow DV, Burn JL, Stull TL. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr 1988; 113: 859-862.
12. Fisher MC, LiPuma JJ, Dasen SE, Caputo GC, Mortensen JE, McGowan KL, Stull TL. Source of Pseudomonas cepacia: Ribotyping of isolates from patients and from the environment. J Pediatr 1993; 123: 745-747.
13. LiPuma JJ, Fisher MC, Dasen SE, Mortensen JE, Stull TL. Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis 1991; 164: 133-136.
14. Carson LA, Anderson RL, Panlilio AL, Beck-Sague CM, Miller JM. Isoenzyme Analysis of Pseudomonas cepacia as an Epidemiologic Tool. J Am Med 1991; 91 (Suppl. 3B): 252S-255S.
15. Heidt A, Monteil H, Richard C. O and H serotyping of Pseudomonas cepacia. J Clin Microbiol 1983; 187: 38-40.
16. Govan JRW, Harris G. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J Clin Microbiol 1985; 22: 490-494.
17. Sajjan SU, Forstner JF. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun 1992; 60: 1434-1440.
18. Anderson DJ, Kuhns JS, Vasil ML, Gerding DN, Janoff EN. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol 1991; 29: 648-649.
19. Kostman JR, Edlind TD, LiPuma JJ, Stull TL. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol 1992; 30: 2084-2087.
20. Lambert MA, Moss CW. Comparison of the effects of acid base hydrolyses on hydroxy and cyclopropane fatty acids in bacteria. J Clin Microbiol 1983; 18: 1370-1377.
21. Smith CL, Klco SR, Cantor CR. Pulsed-field gel electrophoresis and the technology of large DNA molecules, p 41-72. In: Davies K, ed. Genome analysis: a practical approach. Oxford, UK: IRL Press, 1988.
22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DA, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
23. Steinbach S, Sun L, Jiang R, Flume P, Gilligan P, Egan TM, Goldstein R. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994; 331: 981-987.
24. Yamagishi Y, Fujita J, Takigawa K, Negayama K, Nakazawa T, Takahara J. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest 1993; 103: 1706-1709.
25. Honicky R, Harden D, Hsu J et al. Pseudomonas cepacia at summer camps for person with cystic fibrosis. MMWR 1993; 42: 456-459.